(-)-demecolcine increases expression ISO RGD:1354223 6480464 Demecolcine results in increased expression of RALA mRNA CTD PMID:23649840 1,2-dimethylhydrazine multiple interactions ISO RGD:1553390 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RALA mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1553390 6480464 1, 2-Dimethylhydrazine results in decreased expression of RALA mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1553390 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RALA mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1354223 6480464 Estradiol results in increased expression of RALA mRNA CTD PMID:21795739 17beta-estradiol decreases expression ISO RGD:1354223 6480464 Estradiol results in decreased expression of RALA mRNA CTD PMID:31646340 17beta-estradiol multiple interactions ISO RGD:1354223 6480464 Fulvestrant inhibits the reaction [Estradiol results in decreased expression of RALA mRNA] CTD PMID:31646340 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1354223 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553390 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RALA mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RALA mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553390 6480464 Tetrachlorodibenzodioxin affects the expression of RALA mRNA CTD PMID:21570461 2,4,6-tribromophenol decreases expression ISO RGD:1354223 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of RALA mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of RALA mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:1354223 6480464 Lactic Acid results in increased expression of RALA mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1354223 6480464 beta-methylcholine affects the expression of RALA mRNA CTD PMID:21179406 2-nitrotoluene decreases expression EXP 6480464 2-nitrotoluene results in decreased expression of RALA mRNA CTD PMID:16460773 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of RALA mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354223 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RALA mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1553390 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of RALA mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1354223 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RALA mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1354223 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of RALA protein CTD PMID:31945527 , PMID:34186270 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RALA mRNA CTD PMID:30047161 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of RALA mRNA CTD PMID:28959563 all-trans-retinoic acid decreases expression ISO RGD:1354223 6480464 Tretinoin results in decreased expression of RALA mRNA CTD PMID:33167477 amitrole increases expression EXP 6480464 Amitrole results in increased expression of RALA mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of RALA mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1354223 6480464 Antirheumatic Agents results in increased expression of RALA mRNA CTD PMID:24449571 arsenite(3-) decreases expression ISO RGD:1354223 6480464 arsenite results in decreased expression of RALA mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO RGD:1354223 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of RALA mRNA], Fulvestrant inhibits the reaction [arsenite results in decreased expression of RALA mRNA] CTD PMID:31646340 arsenous acid increases expression ISO RGD:1354223 6480464 Arsenic Trioxide results in increased expression of RALA mRNA CTD PMID:20458559 arsenous acid decreases response to substance ISO RGD:1354223 6480464 RALA protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22330069 atazanavir sulfate multiple interactions ISO RGD:1354223 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA CTD PMID:32152650 benzo[a]pyrene decreases expression ISO RGD:1354223 6480464 Benzo(a)pyrene results in decreased expression of RALA mRNA CTD PMID:20064835 , PMID:26238291 benzo[a]pyrene affects methylation ISO RGD:1354223 6480464 Benzo(a)pyrene affects the methylation of RALA 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1354223 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RALA mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1354223 6480464 bisphenol A results in increased expression of RALA protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:1354223 6480464 bisphenol A results in decreased expression of RALA protein CTD PMID:31675489 bisphenol A decreases expression ISO RGD:1553390 6480464 bisphenol A results in decreased expression of RALA mRNA CTD PMID:33221593 bisphenol A multiple interactions ISO RGD:1354223 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RALA protein CTD PMID:31629898 bisphenol A affects expression ISO RGD:1354223 6480464 bisphenol A affects the expression of RALA mRNA CTD PMID:30903817 Bisphenol B increases expression ISO RGD:1354223 6480464 bisphenol B results in increased expression of RALA protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1354223 6480464 bisphenol F results in increased expression of RALA protein CTD PMID:34186270 bortezomib increases expression ISO RGD:1354223 6480464 Bortezomib results in increased expression of RALA mRNA CTD PMID:20977926 bromochloroacetic acid decreases expression EXP 6480464 bromochloroacetic acid results in decreased expression of RALA mRNA CTD PMID:16460773 cadmium atom increases expression ISO RGD:1354223 6480464 Cadmium results in increased expression of RALA mRNA CTD PMID:31646340 cadmium atom multiple interactions ISO RGD:1354223 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RALA mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:1354223 6480464 Cadmium Chloride results in decreased expression of RALA protein CTD PMID:26220685 cadmium dichloride multiple interactions ISO RGD:1354223 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RALA mRNA CTD PMID:35301059 CGP 52608 multiple interactions ISO RGD:1354223 6480464 CGP 52608 promotes the reaction [RORA protein binds to RALA gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:1354223 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA more ... CTD PMID:32152650 chloropicrin increases expression ISO RGD:1354223 6480464 chloropicrin results in increased expression of RALA mRNA CTD PMID:26352163 clofibrate increases expression ISO RGD:1553390 6480464 Clofibrate results in increased expression of RALA mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1354223 6480464 cobaltous chloride results in decreased expression of RALA mRNA CTD PMID:19320972 copper(II) sulfate decreases expression ISO RGD:1354223 6480464 Copper Sulfate results in decreased expression of RALA mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of RALA mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1354223 6480464 Cyclosporine results in increased expression of RALA mRNA CTD PMID:20106945 cyclosporin A multiple interactions ISO RGD:1354223 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA CTD PMID:32152650 deguelin increases expression ISO RGD:1354223 6480464 deguelin results in increased expression of RALA mRNA CTD PMID:33512557 deoxycholic acid multiple interactions ISO RGD:1354223 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA more ... CTD PMID:32152650 dexamethasone multiple interactions ISO RGD:1354223 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RALA mRNA CTD PMID:28628672 diarsenic trioxide decreases response to substance ISO RGD:1354223 6480464 RALA protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22330069 diarsenic trioxide increases expression ISO RGD:1354223 6480464 Arsenic Trioxide results in increased expression of RALA mRNA CTD PMID:20458559 diazinon increases methylation ISO RGD:1354223 6480464 Diazinon results in increased methylation of RALA gene CTD PMID:22964155 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of RALA mRNA CTD PMID:18636392 doxorubicin multiple interactions ISO RGD:1553390 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of RALA mRNA CTD PMID:21040762 ethyl methanesulfonate increases expression ISO RGD:1354223 6480464 Ethyl Methanesulfonate results in increased expression of RALA mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of RALA mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of RALA mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1553390 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RALA mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1354223 6480464 Formaldehyde results in increased expression of RALA mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1354223 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of RALA mRNA] more ... CTD PMID:31646340 fulvestrant increases expression ISO RGD:1354223 6480464 Fulvestrant results in increased expression of RALA mRNA CTD PMID:31646340 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of RALA mRNA CTD PMID:17785943 glycochenodeoxycholic acid multiple interactions ISO RGD:1354223 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA more ... CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:1354223 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:1354223 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA more ... CTD PMID:32152650 glyphosate increases expression ISO RGD:1354223 6480464 glyphosate results in increased expression of RALA mRNA CTD PMID:31295307 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of RALA mRNA CTD PMID:15860345 hydrogen cyanide increases expression ISO RGD:1553390 6480464 Hydrogen Cyanide results in increased expression of RALA mRNA CTD PMID:33914522 indometacin multiple interactions ISO RGD:1354223 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of RALA mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1354223 6480464 Ivermectin results in decreased expression of RALA protein CTD PMID:32959892 lipopolysaccharide multiple interactions ISO RGD:1354223 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RALA mRNA CTD PMID:35877022 methidathion decreases expression ISO RGD:1553390 6480464 methidathion results in decreased expression of RALA mRNA CTD PMID:34813904 methimazole increases expression EXP 6480464 Methimazole results in increased expression of RALA mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO RGD:1354223 6480464 Methyl Methanesulfonate results in increased expression of RALA mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1354223 6480464 methylmercuric chloride results in increased expression of RALA mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1553390 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of RALA protein CTD PMID:26558463 nefazodone increases expression ISO RGD:1354223 6480464 nefazodone results in increased expression of RALA mRNA CTD PMID:32152650 nefazodone multiple interactions ISO RGD:1354223 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of RALA mRNA CTD PMID:32152650 nickel atom increases expression ISO RGD:1354223 6480464 Nickel results in increased expression of RALA mRNA CTD PMID:25583101 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of RALA mRNA CTD PMID:18636392 ozone decreases expression EXP 6480464 Ozone results in decreased expression of RALA mRNA CTD PMID:16330353 pentachlorophenol increases expression ISO RGD:1553390 6480464 Pentachlorophenol results in increased expression of RALA mRNA CTD PMID:23892564 phenol red multiple interactions ISO RGD:1354223 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RALA protein CTD PMID:31629898 picoxystrobin increases expression ISO RGD:1354223 6480464 picoxystrobin results in increased expression of RALA mRNA CTD PMID:33512557 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of RALA mRNA CTD PMID:19162173 pyrimidifen increases expression ISO RGD:1354223 6480464 pyrimidifen results in increased expression of RALA mRNA CTD PMID:33512557 quercetin decreases expression ISO RGD:1354223 6480464 Quercetin results in decreased expression of RALA mRNA CTD PMID:15309432 rac-lactic acid increases expression ISO RGD:1354223 6480464 Lactic Acid results in increased expression of RALA mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO RGD:1354223 6480464 Androgens affects the reaction [Reactive Oxygen Species results in increased activity of RALA protein] CTD PMID:16964283 reactive oxygen species increases activity ISO RGD:1354223 6480464 Reactive Oxygen Species results in increased activity of RALA protein CTD PMID:16964283 rotenone increases expression ISO RGD:1354223 6480464 Rotenone results in increased expression of RALA mRNA CTD PMID:33512557 sodium arsenite affects expression ISO RGD:1354223 6480464 sodium arsenite affects the expression of RALA mRNA CTD PMID:29319823 Soman decreases expression EXP 6480464 Soman results in decreased expression of RALA mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of RALA mRNA CTD PMID:30047161 tert-butyl hydroperoxide increases expression ISO RGD:1354223 6480464 tert-Butylhydroperoxide results in increased expression of RALA mRNA CTD PMID:15336504 tetrachloromethane increases expression ISO RGD:1553390 6480464 Carbon Tetrachloride results in increased expression of RALA mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RALA mRNA CTD PMID:34492290 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of RALA mRNA CTD PMID:19448997 valproic acid increases expression ISO RGD:1354223 6480464 Valproic Acid results in increased expression of RALA mRNA CTD PMID:23179753 , PMID:28001369 zoledronic acid increases expression ISO RGD:1354223 6480464 zoledronic acid results in increased expression of RALA protein CTD PMID:28871336